Compare BAER & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BAER | XGN |
|---|---|---|
| Founded | 2014 | 2002 |
| Country | United States | United States |
| Employees | 235 | N/A |
| Industry | Blank Checks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 113.0M | 110.7M |
| IPO Year | N/A | 2014 |
| Metric | BAER | XGN |
|---|---|---|
| Price | $1.94 | $4.45 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | $5.00 | ★ $8.86 |
| AVG Volume (30 Days) | ★ 455.5K | 208.3K |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $16.47 | $8.12 |
| Revenue Next Year | N/A | $13.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.47 | $2.59 |
| 52 Week High | $3.44 | $12.23 |
| Indicator | BAER | XGN |
|---|---|---|
| Relative Strength Index (RSI) | 51.54 | 49.73 |
| Support Level | $1.58 | $4.11 |
| Resistance Level | $1.97 | $4.93 |
| Average True Range (ATR) | 0.10 | 0.32 |
| MACD | 0.02 | -0.04 |
| Stochastic Oscillator | 61.36 | 26.92 |
Bridger Aerospace Group Holdings Inc operates as an aerial firefighting company. It provides aerial wildfire surveillance, relief and suppression, and aerial firefighting services using next-generation technology and environmentally friendly and sustainable firefighting methods. Its revenues is derived from aerial wildfire management, relief and suppression and the delivery of specialty aviation services. The company's portfolio is organized across three offerings namely : Fire Suppression; Aerial Surveillance; and Maintenance, Repair and Overhaul (MRO). The company operates as a single operating segment. Its revenues are derived from aerial wildfire management, relief and suppression and the delivery of specialty aviation service. Geographically, it operates in Spain and United States.
Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.